Related Experiment Video
Updated: Apr 29, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Using ASMase knockout mice to model human diseases
Guoqiang Hua1, Richard Kolesnick
1Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Abstract:
Acid sphingomyelinase (ASMase) is a key initiator of sphingomyelin/ceramide signal transduction activated by many stress stimuli. Over the past two decades, much progress has been made in defining the clinical relevance of sphingomyelin/ceramide signaling in numerous diseases using ASMase knockout mice. Organs that operate this pathway are numerous and the disease states regulated are diverse, with ceramide generation governing injury in tumor, gut, ovary, brain, lung, heart, liver, and during infection. This chapter emphasizes evolutionary conservation of sphingolipid stress signaling and mammalian adaptations that permit transduction of organotypic responses. Recognition that the sphingomyelin/ceramide transducer calibrates extent of tissue injury, ultimately acting as a molecular switch that determines organ fate, is driving development of new pharmacologic concepts and tools to intervene therapeutically.
Insights
Acid sphingomyelinase (ASMase) initiates sphingomyelin/ceramide signaling, crucial for stress responses. This pathway regulates tissue injury across multiple organs, offering therapeutic intervention targets.
Area of Science:
- Biochemistry
- Cellular Biology
- Physiology
Background:
- Acid sphingomyelinase (ASMase) is a critical enzyme in sphingomyelin/ceramide signaling.
- This pathway is activated by various stress stimuli and implicated in numerous diseases.
- ASMase knockout mice have been instrumental in understanding its clinical relevance.
Purpose of the Study:
- To review the evolutionary conservation of sphingolipid stress signaling.
- To highlight mammalian adaptations in organotypic responses.
- To underscore the role of ceramide generation in organ injury and fate determination.
Main Methods:
- Utilizing data from ASMase knockout mouse models.
- Analyzing evolutionary conservation of sphingolipid pathways.
- Reviewing literature on ceramide generation in disease states.
Main Results:
- Ceramide generation by ASMase governs injury in diverse organs including tumor, gut, ovary, brain, lung, heart, and liver.
- The pathway is evolutionarily conserved, with mammalian adaptations enabling organ-specific responses.
- ASMase acts as a molecular switch determining tissue injury extent and organ fate.
Conclusions:
- Sphingomyelin/ceramide signaling, initiated by ASMase, is a fundamental stress response pathway.
- Understanding this pathway's role in organ injury is vital for therapeutic development.
- Targeting ASMase offers potential for new pharmacologic interventions in various diseases.
More Related Videos
Related Concept Videos
In-vitro Mutagenesis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

